Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases.

Zerilli M, Amato MC, Martorana A, Cabibi D, Coy JF, Cappello F, Pompei G, Russo A, Giordano C, Rodolico V.

Cancer. 2008 Sep 1;113(5):936-44. doi: 10.1002/cncr.23683.

2.

BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid <or=1 cm and their paired lymph node metastases.

Rodolico V, Cabibi D, Pizzolanti G, Richiusa P, Gebbia N, Martorana A, Russo A, Amato MC, Galluzzo A, Giordano C.

Cancer. 2007 Sep 15;110(6):1218-26.

3.
4.

Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.

Koo BS, Choi EC, Yoon YH, Kim DH, Kim EH, Lim YC.

Ann Surg. 2009 May;249(5):840-4. doi: 10.1097/SLA.0b013e3181a40919.

PMID:
19387316
5.

Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.

Buitrago D, Keutgen XM, Crowley M, Filicori F, Aldailami H, Hoda R, Liu YF, Hoda RS, Scognamiglio T, Jin M, Fahey TJ 3rd, Zarnegar R.

Ann Surg Oncol. 2012 Mar;19(3):973-80. doi: 10.1245/s10434-011-2029-0. Epub 2011 Aug 31.

PMID:
21879273
6.

Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.

Galusca B, Dumollard JM, Chambonniere ML, Germain N, Prades JM, Péoc'h M, Estour B.

Anticancer Res. 2004 May-Jun;24(3b):1993-7.

7.

[Effects of transketolase-like gene TKTL1 on occurrence and metastasis of human nasopharyngeal carcinoma].

Zhang S, Yang JH, Cai PC.

Zhonghua Yi Xue Za Zhi. 2008 Dec 2;88(44):3131-4. Chinese.

PMID:
19159596
8.

VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma.

Yasuoka H, Nakamura Y, Zuo H, Tang W, Takamura Y, Miyauchi A, Nakamura M, Mori I, Kakudo K.

Mod Pathol. 2005 Aug;18(8):1127-33.

9.

ret/PTC expression may be associated with local invasion of thyroid papillary carcinoma.

Miki H, Kitaichi M, Masuda E, Komaki K, Yamamoto Y, Monden Y.

J Surg Oncol. 1999 Jun;71(2):76-81; discussion 81-2.

PMID:
10389862
10.
11.

Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.

Yu XM, Lo CY, Lam AK, Leung P, Luk JM.

Ann Surg. 2008 Mar;247(3):483-9. doi: 10.1097/SLA.0b013e31815fa447.

PMID:
18376194
12.

Galectin-3 expression in papillary thyroid carcinoma: relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size.

Cvejic DS, Savin SB, Petrovic IM, Paunovic IR, Tatic SB, Havelka MJ.

Head Neck. 2005 Dec;27(12):1049-55.

PMID:
16155918
13.

Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer.

Földi M, Stickeler E, Bau L, Kretz O, Watermann D, Gitsch G, Kayser G, Zur Hausen A, Coy JF.

Oncol Rep. 2007 Apr;17(4):841-5.

PMID:
17342325
14.

CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis.

Yasuoka H, Kodama R, Hirokawa M, Takamura Y, Miyauchi A, Sanke T, Nakamura Y.

BMC Cancer. 2008 Sep 30;8:274. doi: 10.1186/1471-2407-8-274.

15.

Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.

Lantsov D, Meirmanov S, Nakashima M, Kondo H, Saenko V, Naruke Y, Namba H, Ito M, Abrosimov A, Lushnikov E, Sekine I, Yamashita Sh.

Histopathology. 2005 Sep;47(3):248-56.

PMID:
16115225
16.

Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.

Lam AK, Lo CY, Leung P, Lang BH, Chan WF, Luk JM.

Ann Surg Oncol. 2007 May;14(5):1772-9. Epub 2006 Dec 31.

PMID:
17195959
17.

Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.

Siraj AK, Bavi P, Abubaker J, Jehan Z, Sultana M, Al-Dayel F, Al-Nuaim A, Alzahrani A, Ahmed M, Al-Sanea O, Uddin S, Al-Kuraya KS.

J Pathol. 2007 Oct;213(2):190-9.

PMID:
17703498
18.

Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer.

Yamamoto S, Tomita Y, Uruno T, Hoshida Y, Qiu Y, Iizuka N, Nakamichi I, Miyauchi A, Aozasa K.

Ann Surg Oncol. 2005 Nov;12(11):925-34. Epub 2005 Sep 29.

PMID:
16189643
19.

Papillary thyroid carcinoma with lymph node metastases.

Lin JD.

Growth Factors. 2007 Feb;25(1):41-9. Review.

PMID:
17454149
20.

Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.

Pesutić-Pisac V, Punda A, Gluncić I, Bedeković V, Pranić-Kragić A, Kunac N.

Croat Med J. 2008 Oct;49(5):643-9.

Supplemental Content

Support Center